loading

Tenax Therapeutics Inc (TENX) 最新ニュース

Loss-Making Tenax Therapeutics, Inc. (NASDAQ:TENX) Expected To Breakeven In The Medium-Term - Yahoo Lifestyle UK

pulisher
Yahoo Lifestyle UK

Tenax Therapeutics, Inc. to Post Q2 2024 Earnings of ($1.72) Per Share, Zacks Small Cap Forecasts (NASDAQ:TENX) - Defense World

pulisher
Defense World

TENX: First Quarter Results - Zacks Small Cap Research

pulisher
Zacks Small Cap Research

TENX: First Quarter Results - Yahoo Finance

pulisher
Yahoo Finance

Roth Capital Analysts Reduce Earnings Estimates for Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

pulisher
Defense World

Roth Capital Analysts Reduce Earnings Estimates for Tenax Therapeutics, Inc. (NASDAQ:TENX) - Defense World

pulisher
Defense World

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewswire

pulisher
GlobeNewswire

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - Yahoo Finance

pulisher
Yahoo Finance

Tenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update - 14.05.2024 - wallstreet:online

pulisher
wallstreet:online

Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Update - Defense World

pulisher
Defense World

Tenax Therapeutics Inc expected to post a loss of $2.40 a share - Earnings Preview - XM

pulisher
XM

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with ... - Diagnostic and Interventional Cardiology

pulisher
Diagnostic and Interventional Cardiology

Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with ... - GlobeNewswire

pulisher
GlobeNewswire

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”

pulisher
GlobeNewswire Inc.

Tenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First ... - GlobeNewswire

pulisher
GlobeNewswire

Tenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results - GlobeNewswire

pulisher
GlobeNewswire

Tenax Therapeutics to Present at the 36th Annual Roth Conference - GlobeNewswire

pulisher
GlobeNewswire

Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Tenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024 - GlobeNewswire

pulisher
GlobeNewswire

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

pulisher
GlobeNewswire Inc.

Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan - Yahoo Finance

pulisher
Yahoo Finance

TENX: First Patient Enrolled - Yahoo Finance

pulisher
Yahoo Finance

Crude Oil Gains 3%; Kellanova Posts Upbeat Results

pulisher
Benzinga

Why Compass Minerals International Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Dow Tumbles Over 100 Points; US Initial Jobless Claims Fall Last Week

pulisher
Benzinga

US Stocks Mixed; Disney Earnings Top Views

pulisher
Benzinga

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering

pulisher
GlobeNewswire Inc.

Why Disney Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering - GlobeNewswire

pulisher
GlobeNewswire

Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)

pulisher
GlobeNewswire Inc.

Why Fortinet Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

What's Going On With Tenax Therapeutics Shares? Why Tenax Therapeutics (TENX) Shares Are Jumping Today - - Benzinga

pulisher
Benzinga

Nasdaq Down 50 Points; Willis Towers Watson Posts Upbeat Profit

pulisher
Benzinga

Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Crude Oil Gains 1%; Centene Sales Top Views

pulisher
Benzinga

Dow Jumps Over 100 Points; Eli Lilly Posts Upbeat Earnings

pulisher
Benzinga

Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly ... - GlobeNewswire

pulisher
GlobeNewswire

Why SoFi Technologies Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

TENX Stock Quote Price and Forecast - CNN

pulisher
CNN

Breakeven On The Horizon For Tenax Therapeutics, Inc. (NASDAQ:TENX) - Yahoo Finance

pulisher
Yahoo Finance

Tenax Therapeutics Announces Reverse Stock Split

pulisher
GlobeNewswire Inc.

Tenax Therapeutics Announces Reverse Stock Split - GlobeNewswire

pulisher
GlobeNewswire

Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Hawaiian Airlines Shares Are Trading Higher By Over 180%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of ... - Diagnostic and Interventional Cardiology

pulisher
Diagnostic and Interventional Cardiology

Tenax Therapeutics Announces Professor Javed Butler, M.D., - GlobeNewswire

pulisher
GlobeNewswire

Tenax Thera (NASDAQ: TENX) up 297% on FDA decision - but this is early, early, days - Dhaka Tribune

pulisher
Dhaka Tribune

Dow Surges 100 Points; Tenax Therapeutics Shares Spike Higher - Montauk Renewables (NASDAQ:MNTK), Aclaris - Benzinga

pulisher
Benzinga

TENX: Second Quarter Results - Yahoo Finance

pulisher
Yahoo Finance
$75.07
price up icon 0.79%
$148.85
price down icon 3.50%
$28.20
price up icon 0.75%
$148.43
price down icon 1.07%
$371.02
price up icon 2.45%
$100.60
price up icon 1.87%
大文字化:     |  ボリューム (24 時間):